Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: Implication for treatment of Kawasaki disease

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 373, Issue 5, 2006, Pages 325-332

  Makata, Haruyuki ^a   Ichiyama, Takashi ^a   Uchi, Ryutaro ^a   Takekawa, Tsuyoshi ^a   Matsubara, Tomoyo ^a   Furukawa, Susumu ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Coronary arterial endothelial cells; Dexamethasone; Intravenous immunoglobulin; Monocytes macrophages; T cells

Indexed keywords

CD16 ANTIGEN; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FC RECEPTOR; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 6; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CYTOKINE PRODUCTION; DRUG MEGADOSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MACROPHAGE; MONOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK REDUCTION; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; CORONARY VESSELS; DEXAMETHASONE; E-SELECTIN; ENDOTHELIAL CELLS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERLEUKIN-6; MACROPHAGES; MUCOCUTANEOUS LYMPH NODE SYNDROME; NF-KAPPA B; RECEPTORS, IGG; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747077964     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-006-0084-z     Document Type: Article

References (45)

1. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DY (1992) Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA 89:4066-4070
2. Ariga S, Koga M, Takahashi M, Ishihara T, Matsubara T, Furukawa S (2001) Maturation of macrophages from peripheral blood monocytes in Kawasaki disease: immunocytochemical and immunoelectron macroscopic study. Pathol Int 51:257-263
3. Baeuerle PA, Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179
4. Baldwin AS Jr (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14:649-683
5. Barron K, DeCunto C, Montalvo J, Orson F, Lewis D (1988) Abnormalities of immunoregulation in Kawasaki syndrome. J Rheumatol 15:1243-1249
6. Boehme MW, Schmitt WH, Youinou P, Stremmel WR, Gross WL (1996) Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides. Am J Med 101:387-394
7. Dale RC, Saleem MA, Daw S, Dillon MJ (2000) Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr 137:723-726
8. Fujiwara H, Hamashima Y (1978) Pathology of the heart in Kawasaki disease. Pediatrics 61:100-107
9. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, Kato H, Yabuta K (1988) Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 48:247-251
10. Furukawa S, Matsubara T, Jujoh K, Sasai K, Nakachi S, Sugawara T, Yabuta K, Kato H (1990) Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin. Eur J Pediatr 150:43-47
11. Furukawa S, Matsubara T, Tsuji K, Motohashi T, Okumura K, Yabuta K (1991) Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol 86:134-139
12. Furukawa S, Imai K, Matsubara T, Yone K, Yachi A, Okumura K, Yabuta K (1992a) Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum 35:672-677
13. Furukawa S, Matsubara T, Yabuta K (1992b) Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child 67:706-708
14. Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K (1992c) Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-α and interleukin 6 in serum. Eur J Pediatr 151:44-47
15. Furukawa S, Matsubara T, Tsuji K, Okumura K, Yabuta K (1993) Transient depletion of T cells with bright CD11a/CD18 expression from peripheral circulation during acute Kawasaki disease. Scand J Immunol 37:377-380
16. Furukawa S, Matsubara T, Umezawa Y, Okumura K, Yabuta K (1994) Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr 124:721-725
17. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, Kawarano M, Baba K, Baba K, Mori C (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2:1055-1058
18. Hirao J, Hibi S, Andoh T, Ichimura T (1997) High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 112:152-156
19. Ichiyama T, Yoshitomi T, Nishikawa M, Fujiwara M, Matsubara T, Hayashi T, Furukawa S (2001) NF-κB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin Immunol 99:373-377
20. Ichiyama T, Ueno Y, Isumi H, Niimi A, Matsubara T, Furukawa S (2004a) Intravenous immunoglobulin inhibits NF-κB activation and affects Fcγ receptor expression in monocytes/macrophages. Naunyn-Schmiedebergs Arch Pharmacol 369:428-433
21. Ichiyama T, Ueno Y, Isumi H, Niimi A, Matsubara T, Furukawa S (2004b) An immunoglobulin agent (IVIG) inhibits NF-κB activation in cultured endothelial cells of coronary artery in vitro. Inflamm Res 53:253-256
22. Katayama K, Matsubara T, Fujiwara M, Koga M, Furukawa S (2000) CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol 121:566-570
23. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379-1385
24. Kawasaki T, Kosaki F, Ogawa S, Shigemitsu I, Yanagawa H (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271-276
25. Kim DS, Lee KY (1994) Serum soluble E-selectin levels in Kawasaki disease. Scand J Rheumatol 23:283-286
26. Koga M, Ishihara T, Takahashi M, Umezawa Y, Furukawa S (1998) Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructural and immunocytochemical investigation. Pathol Int 48:512-517
27. Lang GA, Silverman ED, Laxer RM, Lau AS (1989) Spontaneous tumor necrosis factor production in Kawasaki disease. Lancet 2:1298-1302
28. Leung DYM, Chu ET, Wood N, Grady S, Meade R, Geha RS (1983) Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol 130:2002-2004
29. Leung DY, Burns JC, Newburger JW, Geha RS (1987) Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest 79:468-472
30. Leung DYM, Cotran RS, Kurt-Johnes E, Burns JC, Newburger JW, Pober JS (1989) Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. J Pediatr 115:939-943
31. Lin SY, Kinet JP (2001) Giving inhibitory receptors a boost. Science 291:445-446
32. Lin CY, Lin CC, Hwang B, Chiang B (1992) Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor α among patients with Kawasaki disease. J Pediatr 121:924-926
33. Matsubara T, Katayama K, Matsuoka T, Fujiwara M, Koga M, Furukawa S (1999) Decreased interferon-gamma (IFN-γ)-producing T cells in patients with acute Kawasaki disease. Clin Exp Immunol 116:554-557
34. Matsubara T, Ichiyama T, Furukawa S (2005) Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol 141:381-387
35. Maury CP, Salo E, Pelkonen P (1988) Circulating interleukin-1β in patients with Kawasaki disease. N Engl J Med 319:1670-1671
36. Morris HG (1983) Pharmacology of corticosteroids in asthma. In: Middleton Jr E, Reed CE, Ellis EF (eds) Allergy - principles and practice. Mosby, St. Louis, pp 593-600
37. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP, Shulman ST, Wiggins JW, Hicks RV, Fulton DR, Lewis AB, Leung DYM, Colton T, Rosen FS, Melish ME (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347
38. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, Mason WH, Meissner HC, Rowley AH, Shulman ST, Reddy V, Sundel RP, Wiggins JW, Colton T, Melish ME, Rosen FS (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633-1639
39. Okada Y, Shinohara M, Kobayashi T, Inoue Y, Tomomasa T, Kobayashi T, Morikawa A, Gunma Kawasaki Disease Study Group (2003) Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 143:363-367
40. Radeke HH, Janssen-Graalfs I, Sowa EN, Chouchakova N, Skokowa J, Loscher F, Schmidt RE, Heeringa P, Gessner JE (2002) Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis. J Biol Chem 277:27535-27544
41. Sánchez-Mejorada G, Rosales C (1998) Fcγ receptor-mediated mitogen-activated protein kinase activation in monocytes is independent of Ras. J Biol Chem 273:27610-276109
42. Sugawara T, Hattori S, Hirose S, Furukawa S, Yabuta K, Shirai T (1987) Immunopathology of the skin lesions of Kawasaki disease. In: Schulman ST (ed) Kawasaki disease. Liss, New York, pp 185-192
43. Sundel RP, Baker AL, Fulton DR, Newburger JW (2003) Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr 142:611-616
44. Terai M, Kohno Y, Niwa K, Toba T, Sakurai N, Nakajima H (1987) Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 60:555-559
45. Terai M, Kohno Y, Namba M, Umemiya T, Niwa K, Nakajima H, Mikata A (1990) Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol 21:231-234